arrow
E

Ewan R. Pearson

AstraZeneca
H指数:80
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacogenomic study of the effects of saxagliptin on glucose control and hypoglycemic events

沙格列汀对血糖控制和低血糖事件影响药基因组学研究

2026-03-010
PRE
EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism

EndoCompass 项目:糖尿病、肥胖和代谢研究路线图

2025-12-010
PRE
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study

验证一种用于选择2型糖尿病患者SGLT2和DPP4抑制剂疗法的算法在英国主要族裔群体中的有效性:一项回顾性队列研究

2025-11-270
OAAI
Advancing Rare Disease Therapeutics Through Digital Twins: Opportunities in Drug Development and Precision Dosing

通过数字孪生推进罕见病治疗:药物研发和精准给药的机遇

2025-11-230
OAAI
Study protocol for an open-label, single-arm, mixed methods feasibility study of the MWIQ AI-powered decision support tool for diabetes management in GP practices

开放标签、单臂、混合方法可行性研究方案:关于MWIQ人工智能决策支持工具在GP诊所中用于糖尿病管理的可行性研究

2025-10-010
OAAI
EndoCompass project: research roadmap for diabetes, obesity, and metabolism

EndoCompass项目:糖尿病、肥胖和代谢研究的路线图

2025-10-010
PRE
XBP1 expression in pancreatic islet cells is associated with poor glycaemic control especially in young non-obese onset diabetes across ancestries

XBP1在胰腺胰岛细胞中的表达与血糖控制不佳相关,尤其是在不同祖先背景下的年轻非肥胖发病糖尿病中。

2025-09-240
OA
The influence of metformin treatment on the circulating proteome

二甲双胍治疗对循环蛋白质组的影响

2025-07-190
PRE
BMI-residualized data uncovers a cluster of people with type 2 diabetes and increased serum ferritin protected from cardiovascular disease

BMI校正数据揭示了一个由2型糖尿病和血清铁蛋白升高的人群组成的集群,这些人群免受心血管疾病的影响。

2025-03-260
OA